Discover
NVCT
Nuvectis Pharma, Inc.
21.12
2 x 14.79
1 x 20.93
bid
ask
+
0.99
4.92%
2 @ 04:01 PM
21.12 +0.00 (0.00%)
| Ytd | 179.74% | |
| 1y | 251.41% |
19.88
day range
21.26
5.65
52 week range
28.53
| Open | 20.11 | Prev Close | 20.13 | Low | 19.88 | High | 21.26 | Mkt Cap | 689.44M |
| Vol | 152.96K | Avg Vol | 215.43K | EPS | -1.31 | P/E | N/A | Forward P/E | -4.77 |
| Beta | 0.40 | Short Ratio | 5.30 | Inst. Own | 6.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 21.80 | 200-d Avg | 13.72 | 1yr Est | 22.00 |
| Income Statement | |||
| Operating Expenses | 7.20M | ||
| Research and Development Expense | 4.68M | ||
| Selling, General and Administrative Expense | 2.51M | ||
| Operating Income | -7.20M | ||
| Net Income | -7.02M | ||
| Net Income Common Stock | -7.02M | ||
| Net Income Common Stock (USD) | -7.02M | ||
| Consolidated Income | -7.02M | ||
| Earnings per Basic Share | -0.30 | ||
| Earnings per Basic Share (USD) | -0.30 | ||
| Earnings per Diluted Share | -0.30 | ||
| Earning Before Interest & Taxes (EBIT) | -7.02M | ||
| Earning Before Interest & Taxes (USD) | -7.02M | ||
| Weighted Average Shares | 23.48M | ||
| Weighted Average Shares Diluted | 23.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 22.16M | ||
| Cash and Equivalents (USD) | 22.16M | ||
| Current Assets | 22.38M | ||
| Total Assets | 22.38M | ||
| Current Liabilities | 13.29M | ||
| Total Liabilities | 13.29M | ||
| Accumulated Retained Earnings (Deficit) | -112.76M | ||
| Shareholders Equity | 9.08M | ||
| Shareholders Equity (USD) | 9.08M | ||
| Trade and Non-Trade Payables | 5.18M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 1.56M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.97M | ||
| Issuance (Purchase) of Equity Shares | 1.56M | ||
| Net Cash Flow from Operations | -4.53M | ||